- Home
- CRGO vs KZIA Comparison
CRGO vs KZIA Comparison
Compare CRGO & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGO | KZIA |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | Spain | Australia |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.4M | 161.5M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | CRGO | KZIA |
|---|---|---|
| Price | $3.12 | $9.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.67 |
| AVG Volume (30 Days) | 74.6K | ★ 2.0M |
| Earning Date | 11-17-2025 | 12-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $28,642,000.00 | $1,199,108.00 |
| Revenue This Year | $26.59 | N/A |
| Revenue Next Year | $23.43 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.55 | N/A |
| 52 Week Low | $1.72 | $2.86 |
| 52 Week High | $4.42 | $21.00 |
Technical Indicators
Market Signals| Indicator | CRGO | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 43.82 | 46.22 |
| Support Level | $3.04 | $11.75 |
| Resistance Level | $3.22 | $17.40 |
| Average True Range (ATR) | 0.14 | 2.77 |
| MACD | 0.00 | -0.23 |
| Stochastic Oscillator | 24.14 | 18.72 |
Price Performance
Historical ComparisonAbout CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.